nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP3A5—Beclomethasone—psoriasis	0.0598	0.0862	CbGbCtD
Pimozide—CYP1A2—Clobetasol propionate—psoriasis	0.0587	0.0846	CbGbCtD
Pimozide—CYP1A2—Methoxsalen—psoriasis	0.0308	0.0445	CbGbCtD
Pimozide—CYP2D6—Hydroxyurea—psoriasis	0.0278	0.0401	CbGbCtD
Pimozide—CYP3A7—Hydrocortisone—psoriasis	0.0255	0.0367	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0255	0.0367	CbGbCtD
Pimozide—CYP3A7—Cyclosporine—psoriasis	0.024	0.0347	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.024	0.0347	CbGbCtD
Pimozide—CYP3A5—Mycophenolate mofetil—psoriasis	0.0238	0.0343	CbGbCtD
Pimozide—CYP2C19—Cholecalciferol—psoriasis	0.0221	0.0319	CbGbCtD
Pimozide—CYP3A4—Calcitriol—psoriasis	0.0208	0.03	CbGbCtD
Pimozide—CYP3A5—Hydrocortisone—psoriasis	0.0191	0.0275	CbGbCtD
Pimozide—CYP3A5—Cyclosporine—psoriasis	0.018	0.026	CbGbCtD
Pimozide—CYP2D6—Cholecalciferol—psoriasis	0.0168	0.0243	CbGbCtD
Pimozide—CYP3A4—Methoxsalen—psoriasis	0.0162	0.0233	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0158	0.0228	CbGbCtD
Pimozide—CYP3A7—Dexamethasone—psoriasis	0.0158	0.0228	CbGbCtD
Pimozide—ABCB1—Mycophenolate mofetil—psoriasis	0.0155	0.0223	CbGbCtD
Pimozide—CYP2C19—Prednisone—psoriasis	0.0153	0.0221	CbGbCtD
Pimozide—CYP2E1—Dexamethasone—psoriasis	0.0153	0.022	CbGbCtD
Pimozide—CYP2C19—Cyclosporine—psoriasis	0.0146	0.021	CbGbCtD
Pimozide—ABCB1—Betamethasone—psoriasis	0.0133	0.0192	CbGbCtD
Pimozide—ABCB1—Prednisolone—psoriasis	0.0131	0.0189	CbGbCtD
Pimozide—ABCB1—Hydrocortisone—psoriasis	0.0124	0.0179	CbGbCtD
Pimozide—ABCB1—Prednisone—psoriasis	0.0124	0.0179	CbGbCtD
Pimozide—CYP3A5—Dexamethasone—psoriasis	0.0119	0.0171	CbGbCtD
Pimozide—ABCB1—Cyclosporine—psoriasis	0.0117	0.0169	CbGbCtD
Pimozide—CYP2D6—Cyclosporine—psoriasis	0.0111	0.0159	CbGbCtD
Pimozide—CYP3A4—Cholecalciferol—psoriasis	0.0107	0.0154	CbGbCtD
Pimozide—CYP2C19—Dexamethasone—psoriasis	0.00958	0.0138	CbGbCtD
Pimozide—CYP3A4—Triamcinolone—psoriasis	0.00928	0.0134	CbGbCtD
Pimozide—CYP3A4—Mycophenolate mofetil—psoriasis	0.00928	0.0134	CbGbCtD
Pimozide—CYP3A4—Betamethasone—psoriasis	0.00796	0.0115	CbGbCtD
Pimozide—CYP3A4—Prednisolone—psoriasis	0.00786	0.0113	CbGbCtD
Pimozide—ABCB1—Dexamethasone—psoriasis	0.00773	0.0111	CbGbCtD
Pimozide—CYP3A4—Hydrocortisone—psoriasis	0.00745	0.0107	CbGbCtD
Pimozide—CYP3A4—Prednisone—psoriasis	0.00742	0.0107	CbGbCtD
Pimozide—CYP2D6—Dexamethasone—psoriasis	0.00728	0.0105	CbGbCtD
Pimozide—CYP3A4—Cyclosporine—psoriasis	0.00703	0.0101	CbGbCtD
Pimozide—ABCB1—Methotrexate—psoriasis	0.00621	0.00896	CbGbCtD
Pimozide—CYP3A4—Dexamethasone—psoriasis	0.00463	0.00668	CbGbCtD
Pimozide—Visual impairment—Betamethasone—psoriasis	0.000215	0.00101	CcSEcCtD
Pimozide—Dry mouth—Cyclosporine—psoriasis	0.000213	0.000999	CcSEcCtD
Pimozide—Myalgia—Mycophenolate mofetil—psoriasis	0.000212	0.000997	CcSEcCtD
Pimozide—Chest pain—Mycophenolate mofetil—psoriasis	0.000212	0.000997	CcSEcCtD
Pimozide—Breast disorder—Methotrexate—psoriasis	0.000212	0.000995	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000211	0.00099	CcSEcCtD
Pimozide—Diarrhoea—Hydroxyurea—psoriasis	0.000211	0.000989	CcSEcCtD
Pimozide—Syncope—Prednisolone—psoriasis	0.000208	0.00098	CcSEcCtD
Pimozide—Eye disorder—Betamethasone—psoriasis	0.000208	0.000978	CcSEcCtD
Pimozide—Eye disorder—Dexamethasone—psoriasis	0.000208	0.000978	CcSEcCtD
Pimozide—Dry mouth—Mycophenolate mofetil—psoriasis	0.000207	0.000975	CcSEcCtD
Pimozide—Nervous system disorder—Cyclosporine—psoriasis	0.000204	0.000961	CcSEcCtD
Pimozide—Loss of consciousness—Prednisolone—psoriasis	0.000204	0.00096	CcSEcCtD
Pimozide—Syncope—Hydrocortisone—psoriasis	0.000204	0.000957	CcSEcCtD
Pimozide—Dizziness—Hydroxyurea—psoriasis	0.000203	0.000956	CcSEcCtD
Pimozide—Skin disorder—Cyclosporine—psoriasis	0.000203	0.000952	CcSEcCtD
Pimozide—Hyperhidrosis—Cyclosporine—psoriasis	0.000202	0.000947	CcSEcCtD
Pimozide—Convulsion—Prednisolone—psoriasis	0.000201	0.000946	CcSEcCtD
Pimozide—Hypertension—Prednisolone—psoriasis	0.000201	0.000943	CcSEcCtD
Pimozide—Eosinophilia—Methotrexate—psoriasis	0.000201	0.000943	CcSEcCtD
Pimozide—Shock—Mycophenolate mofetil—psoriasis	0.0002	0.00094	CcSEcCtD
Pimozide—Loss of consciousness—Hydrocortisone—psoriasis	0.0002	0.000938	CcSEcCtD
Pimozide—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000199	0.000937	CcSEcCtD
Pimozide—Anorexia—Cyclosporine—psoriasis	0.000199	0.000934	CcSEcCtD
Pimozide—Tachycardia—Mycophenolate mofetil—psoriasis	0.000198	0.000933	CcSEcCtD
Pimozide—Skin disorder—Mycophenolate mofetil—psoriasis	0.000198	0.000928	CcSEcCtD
Pimozide—Convulsion—Hydrocortisone—psoriasis	0.000197	0.000924	CcSEcCtD
Pimozide—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000197	0.000924	CcSEcCtD
Pimozide—Hypertension—Hydrocortisone—psoriasis	0.000196	0.000921	CcSEcCtD
Pimozide—Vomiting—Hydroxyurea—psoriasis	0.000196	0.000919	CcSEcCtD
Pimozide—Abdominal discomfort—Methotrexate—psoriasis	0.000194	0.000913	CcSEcCtD
Pimozide—Rash—Hydroxyurea—psoriasis	0.000194	0.000912	CcSEcCtD
Pimozide—Anorexia—Mycophenolate mofetil—psoriasis	0.000194	0.000911	CcSEcCtD
Pimozide—Dermatitis—Hydroxyurea—psoriasis	0.000194	0.000911	CcSEcCtD
Pimozide—Myalgia—Hydrocortisone—psoriasis	0.000193	0.000908	CcSEcCtD
Pimozide—Headache—Hydroxyurea—psoriasis	0.000193	0.000906	CcSEcCtD
Pimozide—Pancytopenia—Methotrexate—psoriasis	0.000192	0.000904	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000192	0.000902	CcSEcCtD
Pimozide—Syncope—Triamcinolone—psoriasis	0.000192	0.000901	CcSEcCtD
Pimozide—Connective tissue disorder—Prednisone—psoriasis	0.000191	0.000896	CcSEcCtD
Pimozide—Hypotension—Mycophenolate mofetil—psoriasis	0.00019	0.000893	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.00019	0.000893	CcSEcCtD
Pimozide—Insomnia—Cyclosporine—psoriasis	0.000189	0.000886	CcSEcCtD
Pimozide—Loss of consciousness—Triamcinolone—psoriasis	0.000188	0.000883	CcSEcCtD
Pimozide—Shock—Prednisolone—psoriasis	0.000187	0.000877	CcSEcCtD
Pimozide—Erectile dysfunction—Methotrexate—psoriasis	0.000187	0.000877	CcSEcCtD
Pimozide—Somnolence—Cyclosporine—psoriasis	0.000185	0.000871	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000185	0.000871	CcSEcCtD
Pimozide—Convulsion—Triamcinolone—psoriasis	0.000185	0.00087	CcSEcCtD
Pimozide—Tachycardia—Prednisolone—psoriasis	0.000185	0.00087	CcSEcCtD
Pimozide—Asthenia—Mycophenolic acid—psoriasis	0.000185	0.000869	CcSEcCtD
Pimozide—Hypertension—Triamcinolone—psoriasis	0.000185	0.000867	CcSEcCtD
Pimozide—Insomnia—Mycophenolate mofetil—psoriasis	0.000184	0.000864	CcSEcCtD
Pimozide—Hyperhidrosis—Prednisolone—psoriasis	0.000183	0.000862	CcSEcCtD
Pimozide—Nausea—Hydroxyurea—psoriasis	0.000183	0.000859	CcSEcCtD
Pimozide—Pruritus—Mycophenolic acid—psoriasis	0.000182	0.000857	CcSEcCtD
Pimozide—Shock—Hydrocortisone—psoriasis	0.000182	0.000857	CcSEcCtD
Pimozide—Myalgia—Triamcinolone—psoriasis	0.000182	0.000855	CcSEcCtD
Pimozide—Nervous system disorder—Hydrocortisone—psoriasis	0.000182	0.000854	CcSEcCtD
Pimozide—Eye disorder—Prednisone—psoriasis	0.000181	0.000852	CcSEcCtD
Pimozide—Decreased appetite—Cyclosporine—psoriasis	0.000181	0.000852	CcSEcCtD
Pimozide—Tachycardia—Hydrocortisone—psoriasis	0.000181	0.00085	CcSEcCtD
Pimozide—Somnolence—Mycophenolate mofetil—psoriasis	0.000181	0.00085	CcSEcCtD
Pimozide—Drowsiness—Methotrexate—psoriasis	0.000181	0.000849	CcSEcCtD
Pimozide—Depression—Methotrexate—psoriasis	0.00018	0.000846	CcSEcCtD
Pimozide—Gastrointestinal disorder—Cyclosporine—psoriasis	0.00018	0.000846	CcSEcCtD
Pimozide—Skin disorder—Hydrocortisone—psoriasis	0.00018	0.000846	CcSEcCtD
Pimozide—Hyperhidrosis—Hydrocortisone—psoriasis	0.000179	0.000842	CcSEcCtD
Pimozide—Constipation—Cyclosporine—psoriasis	0.000178	0.000838	CcSEcCtD
Pimozide—Dry mouth—Triamcinolone—psoriasis	0.000178	0.000836	CcSEcCtD
Pimozide—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000177	0.000831	CcSEcCtD
Pimozide—Anorexia—Hydrocortisone—psoriasis	0.000177	0.00083	CcSEcCtD
Pimozide—Diarrhoea—Mycophenolic acid—psoriasis	0.000176	0.000829	CcSEcCtD
Pimozide—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000176	0.000825	CcSEcCtD
Pimozide—Syncope—Betamethasone—psoriasis	0.000174	0.000817	CcSEcCtD
Pimozide—Syncope—Dexamethasone—psoriasis	0.000174	0.000817	CcSEcCtD
Pimozide—Constipation—Mycophenolate mofetil—psoriasis	0.000174	0.000817	CcSEcCtD
Pimozide—Sweating—Methotrexate—psoriasis	0.000173	0.000814	CcSEcCtD
Pimozide—Hypotension—Hydrocortisone—psoriasis	0.000173	0.000814	CcSEcCtD
Pimozide—Shock—Triamcinolone—psoriasis	0.000172	0.000807	CcSEcCtD
Pimozide—Insomnia—Prednisolone—psoriasis	0.000172	0.000806	CcSEcCtD
Pimozide—Loss of consciousness—Dexamethasone—psoriasis	0.00017	0.000801	CcSEcCtD
Pimozide—Loss of consciousness—Betamethasone—psoriasis	0.00017	0.000801	CcSEcCtD
Pimozide—Dizziness—Mycophenolic acid—psoriasis	0.00017	0.000801	CcSEcCtD
Pimozide—Tachycardia—Triamcinolone—psoriasis	0.00017	0.0008	CcSEcCtD
Pimozide—Mental disorder—Prednisone—psoriasis	0.00017	0.000799	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000169	0.000793	CcSEcCtD
Pimozide—Hyperhidrosis—Triamcinolone—psoriasis	0.000169	0.000792	CcSEcCtD
Pimozide—Agranulocytosis—Methotrexate—psoriasis	0.000169	0.000792	CcSEcCtD
Pimozide—Convulsion—Dexamethasone—psoriasis	0.000168	0.00079	CcSEcCtD
Pimozide—Convulsion—Betamethasone—psoriasis	0.000168	0.00079	CcSEcCtD
Pimozide—Insomnia—Hydrocortisone—psoriasis	0.000168	0.000787	CcSEcCtD
Pimozide—Hypertension—Dexamethasone—psoriasis	0.000167	0.000787	CcSEcCtD
Pimozide—Hypertension—Betamethasone—psoriasis	0.000167	0.000787	CcSEcCtD
Pimozide—Urticaria—Cyclosporine—psoriasis	0.000166	0.000778	CcSEcCtD
Pimozide—Myalgia—Betamethasone—psoriasis	0.000165	0.000776	CcSEcCtD
Pimozide—Myalgia—Dexamethasone—psoriasis	0.000165	0.000776	CcSEcCtD
Pimozide—Vomiting—Mycophenolic acid—psoriasis	0.000164	0.00077	CcSEcCtD
Pimozide—Rash—Mycophenolic acid—psoriasis	0.000162	0.000763	CcSEcCtD
Pimozide—Dermatitis—Mycophenolic acid—psoriasis	0.000162	0.000763	CcSEcCtD
Pimozide—Urticaria—Mycophenolate mofetil—psoriasis	0.000162	0.000759	CcSEcCtD
Pimozide—Headache—Mycophenolic acid—psoriasis	0.000161	0.000759	CcSEcCtD
Pimozide—Decreased appetite—Hydrocortisone—psoriasis	0.000161	0.000757	CcSEcCtD
Pimozide—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.00016	0.000752	CcSEcCtD
Pimozide—Vision blurred—Prednisone—psoriasis	0.000159	0.000748	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000159	0.000747	CcSEcCtD
Pimozide—Insomnia—Triamcinolone—psoriasis	0.000158	0.000741	CcSEcCtD
Pimozide—Visual impairment—Methotrexate—psoriasis	0.000156	0.000734	CcSEcCtD
Pimozide—Anaemia—Prednisone—psoriasis	0.000156	0.000734	CcSEcCtD
Pimozide—Shock—Betamethasone—psoriasis	0.000156	0.000732	CcSEcCtD
Pimozide—Shock—Dexamethasone—psoriasis	0.000156	0.000732	CcSEcCtD
Pimozide—Nervous system disorder—Dexamethasone—psoriasis	0.000155	0.000729	CcSEcCtD
Pimozide—Nervous system disorder—Betamethasone—psoriasis	0.000155	0.000729	CcSEcCtD
Pimozide—Agitation—Prednisone—psoriasis	0.000155	0.000729	CcSEcCtD
Pimozide—Tachycardia—Betamethasone—psoriasis	0.000155	0.000726	CcSEcCtD
Pimozide—Tachycardia—Dexamethasone—psoriasis	0.000155	0.000726	CcSEcCtD
Pimozide—Nausea—Mycophenolic acid—psoriasis	0.000153	0.000719	CcSEcCtD
Pimozide—Hyperhidrosis—Betamethasone—psoriasis	0.000153	0.000719	CcSEcCtD
Pimozide—Hyperhidrosis—Dexamethasone—psoriasis	0.000153	0.000719	CcSEcCtD
Pimozide—Eye disorder—Methotrexate—psoriasis	0.000152	0.000712	CcSEcCtD
Pimozide—Syncope—Prednisone—psoriasis	0.000151	0.000712	CcSEcCtD
Pimozide—Anorexia—Betamethasone—psoriasis	0.000151	0.000709	CcSEcCtD
Pimozide—Anorexia—Dexamethasone—psoriasis	0.000151	0.000709	CcSEcCtD
Pimozide—Urticaria—Prednisolone—psoriasis	0.000151	0.000708	CcSEcCtD
Pimozide—Cardiac disorder—Methotrexate—psoriasis	0.000151	0.000707	CcSEcCtD
Pimozide—Asthenia—Cyclosporine—psoriasis	0.00015	0.000703	CcSEcCtD
Pimozide—Loss of consciousness—Prednisone—psoriasis	0.000148	0.000698	CcSEcCtD
Pimozide—Hypotension—Dexamethasone—psoriasis	0.000148	0.000695	CcSEcCtD
Pimozide—Hypotension—Betamethasone—psoriasis	0.000148	0.000695	CcSEcCtD
Pimozide—Pruritus—Cyclosporine—psoriasis	0.000148	0.000693	CcSEcCtD
Pimozide—Urticaria—Hydrocortisone—psoriasis	0.000147	0.000692	CcSEcCtD
Pimozide—Convulsion—Prednisone—psoriasis	0.000146	0.000688	CcSEcCtD
Pimozide—Asthenia—Mycophenolate mofetil—psoriasis	0.000146	0.000686	CcSEcCtD
Pimozide—Hypertension—Prednisone—psoriasis	0.000146	0.000685	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000144	0.000678	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000144	0.000678	CcSEcCtD
Pimozide—Pruritus—Mycophenolate mofetil—psoriasis	0.000144	0.000676	CcSEcCtD
Pimozide—Myalgia—Prednisone—psoriasis	0.000144	0.000676	CcSEcCtD
Pimozide—Insomnia—Dexamethasone—psoriasis	0.000143	0.000673	CcSEcCtD
Pimozide—Insomnia—Betamethasone—psoriasis	0.000143	0.000673	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000143	0.000671	CcSEcCtD
Pimozide—Diarrhoea—Cyclosporine—psoriasis	0.000143	0.00067	CcSEcCtD
Pimozide—Mental disorder—Methotrexate—psoriasis	0.000142	0.000668	CcSEcCtD
Pimozide—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000139	0.000654	CcSEcCtD
Pimozide—Urticaria—Triamcinolone—psoriasis	0.000139	0.000651	CcSEcCtD
Pimozide—Dizziness—Cyclosporine—psoriasis	0.000138	0.000648	CcSEcCtD
Pimozide—Decreased appetite—Betamethasone—psoriasis	0.000138	0.000647	CcSEcCtD
Pimozide—Decreased appetite—Dexamethasone—psoriasis	0.000138	0.000647	CcSEcCtD
Pimozide—Gastrointestinal disorder—Betamethasone—psoriasis	0.000137	0.000642	CcSEcCtD
Pimozide—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000137	0.000642	CcSEcCtD
Pimozide—Shock—Prednisone—psoriasis	0.000136	0.000637	CcSEcCtD
Pimozide—Nervous system disorder—Prednisone—psoriasis	0.000135	0.000635	CcSEcCtD
Pimozide—Tachycardia—Prednisone—psoriasis	0.000135	0.000632	CcSEcCtD
Pimozide—Dizziness—Mycophenolate mofetil—psoriasis	0.000134	0.000632	CcSEcCtD
Pimozide—Skin disorder—Prednisone—psoriasis	0.000134	0.000629	CcSEcCtD
Pimozide—Hyperhidrosis—Prednisone—psoriasis	0.000133	0.000626	CcSEcCtD
Pimozide—Vision blurred—Methotrexate—psoriasis	0.000133	0.000625	CcSEcCtD
Pimozide—Asthenia—Hydrocortisone—psoriasis	0.000133	0.000625	CcSEcCtD
Pimozide—Vomiting—Cyclosporine—psoriasis	0.000133	0.000623	CcSEcCtD
Pimozide—Rash—Cyclosporine—psoriasis	0.000131	0.000618	CcSEcCtD
Pimozide—Anorexia—Prednisone—psoriasis	0.000131	0.000617	CcSEcCtD
Pimozide—Dermatitis—Cyclosporine—psoriasis	0.000131	0.000617	CcSEcCtD
Pimozide—Pruritus—Hydrocortisone—psoriasis	0.000131	0.000616	CcSEcCtD
Pimozide—Headache—Cyclosporine—psoriasis	0.000131	0.000614	CcSEcCtD
Pimozide—Anaemia—Methotrexate—psoriasis	0.00013	0.000613	CcSEcCtD
Pimozide—Vomiting—Mycophenolate mofetil—psoriasis	0.000129	0.000608	CcSEcCtD
Pimozide—Rash—Mycophenolate mofetil—psoriasis	0.000128	0.000603	CcSEcCtD
Pimozide—Dermatitis—Mycophenolate mofetil—psoriasis	0.000128	0.000602	CcSEcCtD
Pimozide—Headache—Mycophenolate mofetil—psoriasis	0.000127	0.000599	CcSEcCtD
Pimozide—Diarrhoea—Hydrocortisone—psoriasis	0.000127	0.000596	CcSEcCtD
Pimozide—Leukopenia—Methotrexate—psoriasis	0.000126	0.000594	CcSEcCtD
Pimozide—Urticaria—Dexamethasone—psoriasis	0.000126	0.000591	CcSEcCtD
Pimozide—Urticaria—Betamethasone—psoriasis	0.000126	0.000591	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Prednisone—psoriasis	0.000126	0.00059	CcSEcCtD
Pimozide—Dizziness—Prednisolone—psoriasis	0.000125	0.000589	CcSEcCtD
Pimozide—Asthenia—Triamcinolone—psoriasis	0.000125	0.000588	CcSEcCtD
Pimozide—Insomnia—Prednisone—psoriasis	0.000125	0.000586	CcSEcCtD
Pimozide—Nausea—Cyclosporine—psoriasis	0.000124	0.000582	CcSEcCtD
Pimozide—Pruritus—Triamcinolone—psoriasis	0.000123	0.00058	CcSEcCtD
Pimozide—Dizziness—Hydrocortisone—psoriasis	0.000123	0.000576	CcSEcCtD
Pimozide—Convulsion—Methotrexate—psoriasis	0.000122	0.000575	CcSEcCtD
Pimozide—Nausea—Mycophenolate mofetil—psoriasis	0.000121	0.000568	CcSEcCtD
Pimozide—Myalgia—Methotrexate—psoriasis	0.00012	0.000565	CcSEcCtD
Pimozide—Chest pain—Methotrexate—psoriasis	0.00012	0.000565	CcSEcCtD
Pimozide—Decreased appetite—Prednisone—psoriasis	0.00012	0.000563	CcSEcCtD
Pimozide—Rash—Prednisolone—psoriasis	0.00012	0.000562	CcSEcCtD
Pimozide—Dermatitis—Prednisolone—psoriasis	0.00012	0.000562	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000119	0.000561	CcSEcCtD
Pimozide—Headache—Prednisolone—psoriasis	0.000119	0.000558	CcSEcCtD
Pimozide—Constipation—Prednisone—psoriasis	0.000118	0.000554	CcSEcCtD
Pimozide—Vomiting—Hydrocortisone—psoriasis	0.000118	0.000554	CcSEcCtD
Pimozide—Rash—Hydrocortisone—psoriasis	0.000117	0.000549	CcSEcCtD
Pimozide—Dermatitis—Hydrocortisone—psoriasis	0.000117	0.000548	CcSEcCtD
Pimozide—Headache—Hydrocortisone—psoriasis	0.000116	0.000545	CcSEcCtD
Pimozide—Dizziness—Triamcinolone—psoriasis	0.000115	0.000542	CcSEcCtD
Pimozide—Asthenia—Dexamethasone—psoriasis	0.000114	0.000534	CcSEcCtD
Pimozide—Asthenia—Betamethasone—psoriasis	0.000114	0.000534	CcSEcCtD
Pimozide—Nervous system disorder—Methotrexate—psoriasis	0.000113	0.000531	CcSEcCtD
Pimozide—Nausea—Prednisolone—psoriasis	0.000113	0.000529	CcSEcCtD
Pimozide—Pruritus—Dexamethasone—psoriasis	0.000112	0.000526	CcSEcCtD
Pimozide—Pruritus—Betamethasone—psoriasis	0.000112	0.000526	CcSEcCtD
Pimozide—Skin disorder—Methotrexate—psoriasis	0.000112	0.000526	CcSEcCtD
Pimozide—Hyperhidrosis—Methotrexate—psoriasis	0.000111	0.000523	CcSEcCtD
Pimozide—Vomiting—Triamcinolone—psoriasis	0.000111	0.000521	CcSEcCtD
Pimozide—Nausea—Hydrocortisone—psoriasis	0.00011	0.000517	CcSEcCtD
Pimozide—Rash—Triamcinolone—psoriasis	0.00011	0.000517	CcSEcCtD
Pimozide—Dermatitis—Triamcinolone—psoriasis	0.00011	0.000516	CcSEcCtD
Pimozide—Anorexia—Methotrexate—psoriasis	0.00011	0.000516	CcSEcCtD
Pimozide—Urticaria—Prednisone—psoriasis	0.00011	0.000515	CcSEcCtD
Pimozide—Headache—Triamcinolone—psoriasis	0.000109	0.000514	CcSEcCtD
Pimozide—Diarrhoea—Betamethasone—psoriasis	0.000108	0.000509	CcSEcCtD
Pimozide—Diarrhoea—Dexamethasone—psoriasis	0.000108	0.000509	CcSEcCtD
Pimozide—Hypotension—Methotrexate—psoriasis	0.000108	0.000506	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000105	0.000493	CcSEcCtD
Pimozide—Dizziness—Dexamethasone—psoriasis	0.000105	0.000492	CcSEcCtD
Pimozide—Dizziness—Betamethasone—psoriasis	0.000105	0.000492	CcSEcCtD
Pimozide—Insomnia—Methotrexate—psoriasis	0.000104	0.00049	CcSEcCtD
Pimozide—Nausea—Triamcinolone—psoriasis	0.000104	0.000487	CcSEcCtD
Pimozide—Somnolence—Methotrexate—psoriasis	0.000102	0.000481	CcSEcCtD
Pimozide—Vomiting—Betamethasone—psoriasis	0.000101	0.000473	CcSEcCtD
Pimozide—Vomiting—Dexamethasone—psoriasis	0.000101	0.000473	CcSEcCtD
Pimozide—Decreased appetite—Methotrexate—psoriasis	0.0001	0.000471	CcSEcCtD
Pimozide—Rash—Dexamethasone—psoriasis	9.98e-05	0.000469	CcSEcCtD
Pimozide—Rash—Betamethasone—psoriasis	9.98e-05	0.000469	CcSEcCtD
Pimozide—Dermatitis—Dexamethasone—psoriasis	9.97e-05	0.000469	CcSEcCtD
Pimozide—Dermatitis—Betamethasone—psoriasis	9.97e-05	0.000469	CcSEcCtD
Pimozide—Gastrointestinal disorder—Methotrexate—psoriasis	9.95e-05	0.000467	CcSEcCtD
Pimozide—Headache—Betamethasone—psoriasis	9.92e-05	0.000466	CcSEcCtD
Pimozide—Headache—Dexamethasone—psoriasis	9.92e-05	0.000466	CcSEcCtD
Pimozide—Asthenia—Prednisone—psoriasis	9.89e-05	0.000465	CcSEcCtD
Pimozide—Pruritus—Prednisone—psoriasis	9.75e-05	0.000458	CcSEcCtD
Pimozide—Diarrhoea—Prednisone—psoriasis	9.43e-05	0.000443	CcSEcCtD
Pimozide—Nausea—Dexamethasone—psoriasis	9.4e-05	0.000442	CcSEcCtD
Pimozide—Nausea—Betamethasone—psoriasis	9.4e-05	0.000442	CcSEcCtD
Pimozide—Urticaria—Methotrexate—psoriasis	9.15e-05	0.00043	CcSEcCtD
Pimozide—Dizziness—Prednisone—psoriasis	9.12e-05	0.000428	CcSEcCtD
Pimozide—Vomiting—Prednisone—psoriasis	8.77e-05	0.000412	CcSEcCtD
Pimozide—Rash—Prednisone—psoriasis	8.69e-05	0.000408	CcSEcCtD
Pimozide—Dermatitis—Prednisone—psoriasis	8.68e-05	0.000408	CcSEcCtD
Pimozide—Headache—Prednisone—psoriasis	8.64e-05	0.000406	CcSEcCtD
Pimozide—Asthenia—Methotrexate—psoriasis	8.27e-05	0.000388	CcSEcCtD
Pimozide—Nausea—Prednisone—psoriasis	8.19e-05	0.000385	CcSEcCtD
Pimozide—Pruritus—Methotrexate—psoriasis	8.15e-05	0.000383	CcSEcCtD
Pimozide—Diarrhoea—Methotrexate—psoriasis	7.88e-05	0.00037	CcSEcCtD
Pimozide—Dizziness—Methotrexate—psoriasis	7.62e-05	0.000358	CcSEcCtD
Pimozide—Vomiting—Methotrexate—psoriasis	7.33e-05	0.000344	CcSEcCtD
Pimozide—Rash—Methotrexate—psoriasis	7.26e-05	0.000341	CcSEcCtD
Pimozide—Dermatitis—Methotrexate—psoriasis	7.26e-05	0.000341	CcSEcCtD
Pimozide—Headache—Methotrexate—psoriasis	7.22e-05	0.000339	CcSEcCtD
Pimozide—Nausea—Methotrexate—psoriasis	6.84e-05	0.000322	CcSEcCtD
Pimozide—CALM2—Hemostasis—VEGFA—psoriasis	1.27e-05	0.000136	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—VEGFA—psoriasis	1.27e-05	0.000136	CbGpPWpGaD
Pimozide—CALM3—Metabolism—CAT—psoriasis	1.27e-05	0.000136	CbGpPWpGaD
Pimozide—CALM3—Disease—HLA-A—psoriasis	1.26e-05	0.000135	CbGpPWpGaD
Pimozide—CALM2—Immune System—CRP—psoriasis	1.26e-05	0.000135	CbGpPWpGaD
Pimozide—CALM1—Immune System—CRP—psoriasis	1.26e-05	0.000135	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—TYK2—psoriasis	1.26e-05	0.000135	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—NFKB1—psoriasis	1.26e-05	0.000135	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—NFKB1—psoriasis	1.26e-05	0.000135	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.25e-05	0.000134	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—NFKB1—psoriasis	1.25e-05	0.000134	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CARM1—psoriasis	1.25e-05	0.000134	CbGpPWpGaD
Pimozide—CALM3—Immune System—HLA-DRB1—psoriasis	1.25e-05	0.000134	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—NFKBIA—psoriasis	1.24e-05	0.000133	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.23e-05	0.000132	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—NFKBIA—psoriasis	1.23e-05	0.000132	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.23e-05	0.000132	CbGpPWpGaD
Pimozide—CALM1—Metabolism—CAT—psoriasis	1.23e-05	0.000132	CbGpPWpGaD
Pimozide—CALM2—Metabolism—CAT—psoriasis	1.23e-05	0.000132	CbGpPWpGaD
Pimozide—CALM1—Disease—HLA-A—psoriasis	1.22e-05	0.000131	CbGpPWpGaD
Pimozide—CALM2—Disease—HLA-A—psoriasis	1.22e-05	0.000131	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—NFKB1—psoriasis	1.21e-05	0.00013	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—NFKB1—psoriasis	1.21e-05	0.00013	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	1.21e-05	0.000129	CbGpPWpGaD
Pimozide—CALM2—Immune System—HLA-DRB1—psoriasis	1.21e-05	0.000129	CbGpPWpGaD
Pimozide—CALM1—Immune System—HLA-DRB1—psoriasis	1.21e-05	0.000129	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TYK2—psoriasis	1.2e-05	0.000129	CbGpPWpGaD
Pimozide—CALM3—Immune System—ICAM1—psoriasis	1.2e-05	0.000128	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—PPARG—psoriasis	1.19e-05	0.000128	CbGpPWpGaD
Pimozide—CALM3—Immune System—NFKBIA—psoriasis	1.19e-05	0.000127	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TYK2—psoriasis	1.19e-05	0.000127	CbGpPWpGaD
Pimozide—CALM3—Disease—APOE—psoriasis	1.18e-05	0.000126	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.17e-05	0.000125	CbGpPWpGaD
Pimozide—CALM2—Immune System—ICAM1—psoriasis	1.16e-05	0.000124	CbGpPWpGaD
Pimozide—CALM1—Immune System—ICAM1—psoriasis	1.16e-05	0.000124	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—LEP—psoriasis	1.15e-05	0.000123	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—APOE—psoriasis	1.15e-05	0.000123	CbGpPWpGaD
Pimozide—CALM2—Immune System—NFKBIA—psoriasis	1.15e-05	0.000123	CbGpPWpGaD
Pimozide—CALM1—Immune System—NFKBIA—psoriasis	1.15e-05	0.000123	CbGpPWpGaD
Pimozide—CALM2—Disease—APOE—psoriasis	1.14e-05	0.000122	CbGpPWpGaD
Pimozide—CALM1—Disease—APOE—psoriasis	1.14e-05	0.000122	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—CXCL8—psoriasis	1.14e-05	0.000122	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—CXCL8—psoriasis	1.12e-05	0.00012	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SOCS1—psoriasis	1.12e-05	0.00012	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—CXCL8—psoriasis	1.12e-05	0.000119	CbGpPWpGaD
Pimozide—CALM3—Disease—NOS2—psoriasis	1.1e-05	0.000118	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—CXCL8—psoriasis	1.1e-05	0.000118	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SOCS1—psoriasis	1.08e-05	0.000116	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SOCS1—psoriasis	1.08e-05	0.000116	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—NFKBIA—psoriasis	1.07e-05	0.000115	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—TYK2—psoriasis	1.07e-05	0.000114	CbGpPWpGaD
Pimozide—CALM2—Disease—NOS2—psoriasis	1.06e-05	0.000114	CbGpPWpGaD
Pimozide—CALM1—Disease—NOS2—psoriasis	1.06e-05	0.000114	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CXCL8—psoriasis	1.05e-05	0.000112	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CXCL8—psoriasis	1.03e-05	0.000111	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—TYK2—psoriasis	1.03e-05	0.00011	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—TYK2—psoriasis	1.03e-05	0.00011	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TYK2—psoriasis	1.02e-05	0.000109	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—LEP—psoriasis	1.01e-05	0.000108	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—APOE—psoriasis	1.01e-05	0.000108	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TYK2—psoriasis	1.01e-05	0.000108	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—IL6—psoriasis	9.97e-06	0.000107	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—LEP—psoriasis	9.94e-06	0.000106	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—APOE—psoriasis	9.94e-06	0.000106	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—APOE—psoriasis	9.93e-06	0.000106	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—TP53—psoriasis	9.93e-06	0.000106	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—LEP—psoriasis	9.92e-06	0.000106	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—APOE—psoriasis	9.92e-06	0.000106	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—APOE—psoriasis	9.91e-06	0.000106	CbGpPWpGaD
Pimozide—CALM3—Metabolism—APOE—psoriasis	9.87e-06	0.000106	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—CAT—psoriasis	9.86e-06	0.000106	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—IL6—psoriasis	9.82e-06	0.000105	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—LEP—psoriasis	9.76e-06	0.000104	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—APOE—psoriasis	9.76e-06	0.000104	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—JUN—psoriasis	9.74e-06	0.000104	CbGpPWpGaD
Pimozide—CALM3—Immune System—TYK2—psoriasis	9.74e-06	0.000104	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CARM1—psoriasis	9.64e-06	0.000103	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—CAT—psoriasis	9.63e-06	0.000103	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—JUN—psoriasis	9.6e-06	0.000103	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—TP53—psoriasis	9.6e-06	0.000103	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—TP53—psoriasis	9.6e-06	0.000103	CbGpPWpGaD
Pimozide—CALM1—Metabolism—APOE—psoriasis	9.55e-06	0.000102	CbGpPWpGaD
Pimozide—CALM2—Metabolism—APOE—psoriasis	9.55e-06	0.000102	CbGpPWpGaD
Pimozide—CALM1—Immune System—TYK2—psoriasis	9.42e-06	0.000101	CbGpPWpGaD
Pimozide—CALM2—Immune System—TYK2—psoriasis	9.42e-06	0.000101	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NFKBIA—psoriasis	9.41e-06	0.000101	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—NFKB1—psoriasis	9.38e-06	0.0001	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—CXCL8—psoriasis	9.28e-06	9.94e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NFKBIA—psoriasis	9.26e-06	9.92e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—NFKB1—psoriasis	9.24e-06	9.9e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NFKBIA—psoriasis	9.24e-06	9.9e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IFNG—psoriasis	9.12e-06	9.77e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NFKBIA—psoriasis	9.09e-06	9.74e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CAT—psoriasis	9.07e-06	9.71e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—TYK2—psoriasis	8.99e-06	9.63e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—CXCL8—psoriasis	8.98e-06	9.61e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—CXCL8—psoriasis	8.98e-06	9.61e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CXCL8—psoriasis	8.86e-06	9.48e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IFNG—psoriasis	8.82e-06	9.45e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IFNG—psoriasis	8.82e-06	9.45e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD4—psoriasis	8.81e-06	9.43e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TYK2—psoriasis	8.78e-06	9.4e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CXCL8—psoriasis	8.77e-06	9.39e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—TYK2—psoriasis	8.7e-06	9.31e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—TYK2—psoriasis	8.7e-06	9.31e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PPARG—psoriasis	8.65e-06	9.26e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PPARG—psoriasis	8.63e-06	9.24e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PPARG—psoriasis	8.6e-06	9.2e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD4—psoriasis	8.52e-06	9.12e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—CD4—psoriasis	8.52e-06	9.12e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—VEGFA—psoriasis	8.51e-06	9.11e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—STAT3—psoriasis	8.43e-06	9.02e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—IL6—psoriasis	8.42e-06	9.02e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—VEGFA—psoriasis	8.39e-06	8.98e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—IL6—psoriasis	8.34e-06	8.93e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PPARG—psoriasis	8.32e-06	8.9e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PPARG—psoriasis	8.32e-06	8.9e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—STAT3—psoriasis	8.31e-06	8.89e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—LEP—psoriasis	8.25e-06	8.83e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—APOE—psoriasis	8.25e-06	8.83e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—JUN—psoriasis	8.24e-06	8.82e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—IL6—psoriasis	8.18e-06	8.76e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—JUN—psoriasis	8.16e-06	8.73e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—CD4—psoriasis	8.13e-06	8.71e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—APOE—psoriasis	7.98e-06	8.55e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—LEP—psoriasis	7.98e-06	8.55e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—APOE—psoriasis	7.98e-06	8.55e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—LEP—psoriasis	7.98e-06	8.55e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—NFKB1—psoriasis	7.93e-06	8.49e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—IL6—psoriasis	7.91e-06	8.47e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—IL6—psoriasis	7.91e-06	8.47e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—JUN—psoriasis	7.88e-06	8.44e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—CD4—psoriasis	7.87e-06	8.42e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—CD4—psoriasis	7.87e-06	8.42e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—NFKB1—psoriasis	7.85e-06	8.41e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TYK2—psoriasis	7.71e-06	8.25e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NFKBIA—psoriasis	7.69e-06	8.23e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CAT—psoriasis	7.68e-06	8.23e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—APOE—psoriasis	7.66e-06	8.2e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CXCL8—psoriasis	7.65e-06	8.19e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—JUN—psoriasis	7.63e-06	8.17e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—JUN—psoriasis	7.63e-06	8.17e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—NFKB1—psoriasis	7.59e-06	8.13e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TYK2—psoriasis	7.59e-06	8.12e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TYK2—psoriasis	7.57e-06	8.1e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—APOE—psoriasis	7.48e-06	8.01e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TYK2—psoriasis	7.45e-06	7.98e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NFKBIA—psoriasis	7.44e-06	7.96e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NFKBIA—psoriasis	7.44e-06	7.96e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—NFKB1—psoriasis	7.34e-06	7.86e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—NFKB1—psoriasis	7.34e-06	7.86e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—IL6—psoriasis	7.27e-06	7.78e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—VEGFA—psoriasis	7.19e-06	7.7e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—VEGFA—psoriasis	7.13e-06	7.63e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—STAT3—psoriasis	7.12e-06	7.63e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—JUN—psoriasis	7.11e-06	7.61e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—STAT3—psoriasis	7.06e-06	7.55e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—APOE—psoriasis	7.05e-06	7.55e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—NFKB1—psoriasis	6.84e-06	7.33e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—STAT3—psoriasis	6.82e-06	7.3e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CXCL8—psoriasis	6.71e-06	7.19e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PPARG—psoriasis	6.67e-06	7.15e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CXCL8—psoriasis	6.61e-06	7.07e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—STAT3—psoriasis	6.6e-06	7.06e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—STAT3—psoriasis	6.6e-06	7.06e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CXCL8—psoriasis	6.59e-06	7.06e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PPARG—psoriasis	6.51e-06	6.97e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CXCL8—psoriasis	6.49e-06	6.94e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TP53—psoriasis	6.43e-06	6.89e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL6—psoriasis	6.38e-06	6.83e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TP53—psoriasis	6.34e-06	6.79e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TYK2—psoriasis	6.3e-06	6.74e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—STAT3—psoriasis	6.3e-06	6.74e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL6—psoriasis	6.28e-06	6.72e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL6—psoriasis	6.27e-06	6.71e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—JUN—psoriasis	6.24e-06	6.68e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—VEGFA—psoriasis	6.21e-06	6.65e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL6—psoriasis	6.17e-06	6.6e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—STAT3—psoriasis	6.15e-06	6.58e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—JUN—psoriasis	6.14e-06	6.57e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PPARG—psoriasis	6.14e-06	6.57e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—JUN—psoriasis	6.13e-06	6.56e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TYK2—psoriasis	6.09e-06	6.52e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TYK2—psoriasis	6.09e-06	6.52e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—STAT3—psoriasis	6.09e-06	6.52e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—STAT3—psoriasis	6.09e-06	6.52e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—JUN—psoriasis	6.03e-06	6.46e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NFKB1—psoriasis	6.01e-06	6.43e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—APOE—psoriasis	5.97e-06	6.39e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CAT—psoriasis	5.93e-06	6.35e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NFKB1—psoriasis	5.91e-06	6.33e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NFKB1—psoriasis	5.9e-06	6.32e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL6—psoriasis	5.89e-06	6.3e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NFKB1—psoriasis	5.8e-06	6.21e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6—psoriasis	5.8e-06	6.21e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCL8—psoriasis	5.48e-06	5.87e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—psoriasis	5.45e-06	5.84e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TP53—psoriasis	5.44e-06	5.82e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—psoriasis	5.4e-06	5.78e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TP53—psoriasis	5.38e-06	5.76e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—psoriasis	5.37e-06	5.74e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—psoriasis	5.35e-06	5.73e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—psoriasis	5.31e-06	5.69e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCL8—psoriasis	5.3e-06	5.68e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCL8—psoriasis	5.3e-06	5.68e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—psoriasis	5.3e-06	5.68e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—psoriasis	5.27e-06	5.64e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—psoriasis	5.22e-06	5.58e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—psoriasis	5.21e-06	5.58e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PPARG—psoriasis	5.2e-06	5.57e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—JUN—psoriasis	5.1e-06	5.46e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—psoriasis	5.04e-06	5.4e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—psoriasis	5.04e-06	5.4e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—psoriasis	4.98e-06	5.33e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—JUN—psoriasis	4.93e-06	5.28e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—JUN—psoriasis	4.93e-06	5.28e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—psoriasis	4.93e-06	5.28e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NFKB1—psoriasis	4.91e-06	5.25e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—psoriasis	4.76e-06	5.1e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NFKB1—psoriasis	4.75e-06	5.08e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NFKB1—psoriasis	4.75e-06	5.08e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TP53—psoriasis	4.69e-06	5.02e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—psoriasis	4.61e-06	4.93e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—psoriasis	4.61e-06	4.93e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOE—psoriasis	4.61e-06	4.93e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—psoriasis	4.45e-06	4.77e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—psoriasis	4.41e-06	4.72e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—psoriasis	4.4e-06	4.71e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—psoriasis	4.31e-06	4.61e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—psoriasis	4.31e-06	4.61e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—psoriasis	4.3e-06	4.6e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—psoriasis	4.27e-06	4.57e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—psoriasis	4.27e-06	4.57e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—psoriasis	4.26e-06	4.56e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—psoriasis	4.26e-06	4.56e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TP53—psoriasis	4.12e-06	4.41e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TP53—psoriasis	4.05e-06	4.34e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TP53—psoriasis	4.05e-06	4.33e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARG—psoriasis	4.01e-06	4.3e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TP53—psoriasis	3.98e-06	4.26e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—psoriasis	3.77e-06	4.04e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—psoriasis	3.71e-06	3.97e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—psoriasis	3.7e-06	3.96e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—psoriasis	3.64e-06	3.9e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TP53—psoriasis	3.37e-06	3.6e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TP53—psoriasis	3.26e-06	3.49e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TP53—psoriasis	3.26e-06	3.49e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—psoriasis	3.08e-06	3.3e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—psoriasis	2.98e-06	3.19e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—psoriasis	2.98e-06	3.19e-05	CbGpPWpGaD
